Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2022 Annual Meeting | Aducanumab: A Conversation with David Knopman About the Approval Process and the Future of Dementia Care

Tuesday 04/05/22
04:00 PM - 04:45 PM PDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (HeadTalks)
Joyce K. Lee-Iannotti, MD, FÂ鶹´«Ã½Ó³»­, David Y. Hwang, MD, FÂ鶹´«Ã½Ó³»­, David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
General Neurology, Aging, Dementia, and Behavioral Neurology
Come learn more about the controversial use of Aducanumab as a treatment for Alzheimer’s disease from a leading authority in Cognitive and Behavioral Neurology, Dr. David Knopman.  Dr. Knopman will guide us in the development of aducanumab, the analysis of the clinical trial data, the approval by the FDA and the subsequent decision by CMS to limit coverage to persons in a controlled clinical trial. He will also update us on forthcoming treatments and the future of dementia care.
No CME available

Program Materials Program Evaluations

Event Timeline
04:00 PM - 04:45 PM PDT Discussion Aducanumab: A Conversation with David Knopman About the Approval Process and the Future of Dementia Care
Joyce K. Lee-Iannotti, MD, FÂ鶹´«Ã½Ó³»­, David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­, David Y. Hwang, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Joyce K. Lee-Iannotti, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lee-Iannotti has nothing to disclose.
David Y. Hwang, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hwang has received research support from NIH. The institution of Dr. Hwang has received research support from Neurocritical Care Foundation. The institution of an immediate family member of Dr. Hwang has received research support from NIH. Dr. Hwang has received personal compensation in the range of $10,000-$49,999 for serving as a Medical Director - Critical Care with New England Donor Services.
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.